Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Bretton Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+14.4%
YTD+11.58%
Annualized+0.1277%
Positioning StanceCONSTRUCTIVE
Market CapAll Cap
Digest Analysis
Quick Take
"The Bretton Fund returned 11.58% in 2025, underperforming the S&P 500 as it maintained a disciplined avoidance of speculative AI tech names and suffered from UnitedHealth's margin compression, while holding strong conviction in housing and core financial leaders."
Executive Summary
In its 2025 letter, Bretton Fund reported a 4th Quarter return of 1.44% and a full-year return of 11.58%, lagging the S&P 500 Index's 2.66% and 17.88% returns. The underperformance was primarily driven by its avoidance of speculative AI stocks and a major decline in UnitedHealth Group (-1.1% portfolio impact), which suffered from unexpectedly high medical costs. Top performing contributors included Alphabet (+65% return), American Express (+26%), and JPMorgan Chase (+37%). The fund exited its positions in Revvity (-5.90% IRR) and Union Pacific (+13.0% IRR). Housing-related investments (NVR, Dream Finders, Eagle Materials) struggled due to high interest rates, but the fund maintains conviction due to historic pent-up demand and lack of inventory.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
80%
Market Conviction
High-conviction positioning: The Bretton Fund returned 11.58% in 2025, underperforming the S&P 500 as it maintained a disciplined avoidance of speculative AI tech names and suffered from UnitedHealth's margin ...
80%
Growth Outlook
Market outlook remains above average conviction: The Bretton Fund returned 11.58% in 2025, underperforming the S&P 500 as it maintained a disciplined avoidance of speculative AI tech names and suffered from UnitedHealth's margin ...
70%
Risk Appetite
Risk appetite posture is moderate conviction: The Bretton Fund returned 11.58% in 2025, underperforming the S&P 500 as it maintained a disciplined avoidance of speculative AI tech names and suffered from UnitedHealth's margin ...
50%
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The Bretton Fund returned 11.58% in 2025, underperforming the S&P 500 as it maintained a disciplined avoidance of speculative AI tech names and suffered from UnitedHealth's margin ...
75%
Forward Guidance
Forward guidance signal: The Bretton Fund returned 11.58% in 2025, underperforming the S&P 500 as it maintained a disciplined avoidance of speculative AI tech names and suffered from UnitedHealth's margin ...
80%
Language Signal
Tone analysis indicates above average conviction language: The Bretton Fund returned 11.58% in 2025, underperforming the S&P 500 as it maintained a disciplined avoidance of speculative AI tech names and suffered from UnitedHealth's margin ...
50%
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The Bretton Fund returned 11.58% in 2025, underperforming the S&P 500 as it maintained a disciplined avoidance of speculative AI tech names and suffered from UnitedHealth's margin ...
70%
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. The Bretton Fund returned 11.58% in 2025, underperforming the S&P 500 as it maintained a disciplined avoidance of speculative AI tech names and suffered from UnitedHealth's margin ...
90%
Time Horizon
Investment time horizon reflects a high conviction orientation. The Bretton Fund returned 11.58% in 2025, underperforming the S&P 500 as it maintained a disciplined avoidance of speculative AI tech names and suffered from UnitedHealth's margin ...